GPT and esophageal cancer: Among men, the very low AST/ALT ratio group showed contrasting results, that is decreased esophageal cancer (adjusted HR 0.37; 95% CI 0.18–0.79) and increased urinary tract/bladder cancer (adjusted HR 2.71; 95% CI 1.02–7.18).